| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629322 Treatment of neurodegenerative disorders, disorders of gastrointestinal motility and inflammation |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629312 Reducing neuron damage caused by gp-120 protein in aids patients |
| 05/13/1997 | US5629308 Imidazo [1,2-A] (pyrrolo, thieno or furano) [2,3-D] azepine derivatives |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629001 Oral administration of therapeutic proteins for treatment of infectious disease |
| 05/13/1997 | US5628988 Sunscreen agents |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016440A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 05/09/1997 | WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/09/1997 | WO1997016438A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016437A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016197A1 Extracts of shark cartilage |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | WO1997016182A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016068A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997003186A3 Method for in vitro proliferation of dentritic cells, composition containing the cells entrapped in a three-dimensional matrix and use for immunization |
| 05/09/1997 | CA2237607A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2236171A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/07/1997 | EP0771869A1 Immunological tolerance inducing agent |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771204A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 05/07/1997 | EP0771199A1 Methods |
| 05/07/1997 | EP0771191A1 Immunological activity of rhamnolipids |
| 05/07/1997 | EP0771147A1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/07/1997 | EP0626956B1 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 05/07/1997 | EP0602050B1 Method of stimulating immune response |
| 05/07/1997 | EP0532716B1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149296A Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CN1149292A Pyrimidinyl derivatives as interleukin inhibitors |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1148968A Extract of Asiatic cornelian cherry with immunosuppression and preparation thereof |
| 05/06/1997 | US5627264 Chimeric complement inhibitor proteins |
| 05/06/1997 | US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine |
| 05/06/1997 | US5627183 Methods for treating urticaria using optically pure (+) cetirizine |
| 05/06/1997 | US5627157 α-glycosyl hesperidin and its uses |
| 05/06/1997 | US5627155 Controlling diseases with proteins such as allergies, psoriasis, tissue rejection and autoimmune diseases |
| 05/02/1997 | EP0770681A2 T cell epitopes of the major allergens from ambrosia artemisiifolia |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770613A1 Substituted Imidazolidin-2,4-dione der4ivatives as immunomodulators |
| 05/02/1997 | EP0770393A2 Prolongation of organ transplantation using rapamycin loaded donor splenocytes |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770385A1 Use of astaxanthin for the treatment of stress |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |
| 05/02/1997 | EP0770081A1 Heterocycle-condensed morphinoid derivatives |
| 05/02/1997 | EP0770079A1 Heterobicyclic derivatives |
| 05/02/1997 | EP0770078A1 8-aryl-1,6-naphthyridin-5-ones |
| 05/02/1997 | EP0770068A1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| 05/02/1997 | EP0770064A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 05/02/1997 | EP0770059A1 Substituted benzamidines, their production and their use as medicaments |
| 05/02/1997 | EP0770058A1 Novel chemical compound, its preparation and use as a drug |
| 05/02/1997 | EP0769967A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 05/02/1997 | EP0769957A1 Methods for treating motor deficits |
| 05/02/1997 | EP0769952A1 Chicken infectious anemia virus vaccine |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769940A1 INDENE sPLA 2? INHIBITORS |
| 05/02/1997 | EP0769939A1 Use of inhibitors of human s-cd23 |
| 05/02/1997 | EP0769902A1 Methods for reducing hyperacute rejection of xenografts |
| 05/01/1997 | WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 05/01/1997 | WO1997015596A1 Human pec-60-like protein and dna encoding the same |
| 05/01/1997 | WO1997015561A1 Chiral methyl phenyl oxazolidinones |
| 05/01/1997 | WO1997015324A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015307A1 Eye drops |
| 05/01/1997 | WO1997015289A1 Solubilisation methods |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235614A1 Eye drops |
| 05/01/1997 | CA2235599A1 High fluorescence specific immune enhancing factor and methods of use for same |
| 05/01/1997 | CA2235487A1 Solubilisation methods |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | CN1148849A Process for preparing anhydrous and hydrate forms of antihistaminic pipeeridine derivatives, polymorphs and spseudormophs thereof |
| 04/30/1997 | CN1148505A Activated immune globulin |
| 04/30/1997 | CN1148503A Application of noval peptidic compound in preparation of medicine |
| 04/30/1997 | CN1148491A Method for preparing medicinal composition in noval physical form containing heterocyclic amide derivative |
| 04/30/1997 | CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 04/29/1997 | US5625067 Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use |
| 04/29/1997 | US5625039 Anti-human IgE monoclonal antibodies |
| 04/29/1997 | US5624957 Retinoid active compounds |
| 04/29/1997 | US5624950 Useful in treatment of analgesia, inflammation, asthma, allergies, central nervous system disorders, cardiovascular disorders, immune system disorders, antispasmodic agents, antiemetic agents |
| 04/29/1997 | US5624945 Use of riluzole for the treatment of neuro-aids |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624934 Protease inhibitors |
| 04/29/1997 | US5624931 Pyrazole derivatives |
| 04/29/1997 | US5624842 Strain of Streptomyces for the production of tricyclo compounds |
| 04/29/1997 | US5624837 Nucleic acid encoding chimeric complement inhibitor proteins |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/29/1997 | CA2089207C Amphoteric tricyclic compound |
| 04/29/1997 | CA2003190C Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid |
| 04/28/1997 | CA2188908A1 Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients |